Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 167

    1.

    Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.

    Pusateri AE, Park MS.

    Crit Care. 2005;9 Suppl 5:S15-24. Epub 2005 Oct 7. Review.PMID: 16221315 [PubMed - indexed for MEDLINE]Related articles

    2.

    The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.

    McMullin NR, Kauvar DS, Currier HM, Baskin TW, Pusateri AE, Holcomb JB.

    Curr Surg. 2006 Jul-Aug;63(4):246-51.PMID: 16843774 [PubMed - indexed for MEDLINE]Related articles

    3.

    In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.

    Kheirabadi BS, Delgado AV, Dubick MA, Scherer MR, Fedyk CG, Holcomb JB, Pusateri AE.

    J Trauma. 2007 Nov;63(5):1079-86.PMID: 17993954 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.

    Hendriks HG, Meijer K, de Wolf JT, Porte RJ, Klompmaker IJ, Lip H, Slooff MJ, van der Meer J.

    Blood Coagul Fibrinolysis. 2002 Jun;13(4):309-13.PMID: 12032396 [PubMed - indexed for MEDLINE]Related articles

    5.

    Recombinant activated factor VII for adjunctive hemorrhage control in trauma.

    Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M.

    J Trauma. 2001 Sep;51(3):431-8; discussion 438-9.PMID: 11535886 [PubMed - indexed for MEDLINE]Related articles

    6.

    Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

    Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.

    Can J Anaesth. 2002 Dec;49(10):S15-20.PMID: 12546003 [PubMed - indexed for MEDLINE]Related articles

    7.

    A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.

    Murkin JM.

    Can J Anaesth. 2002 Dec;49(10):S21-6. Review.PMID: 12546007 [PubMed - indexed for MEDLINE]Related articles

    8.

    The emerging role of recombinant-activated factor VII in neurocritical care.

    Fewel ME, Park P.

    Neurocrit Care. 2004;1(1):19-29. Review.PMID: 16174895 [PubMed - indexed for MEDLINE]Related articles

    9.

    Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

    Allen GA, Hoffman M, Roberts HR, Monroe DM 3rd.

    Can J Anaesth. 2002 Dec;49(10):S7-14. Review.PMID: 12546000 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recombinant activated coagulation factor VII and bleeding trauma patients.

    Rizoli SB, Nascimento B Jr, Osman F, Netto FS, Kiss A, Callum J, Brenneman FD, Tremblay L, Tien HC.

    J Trauma. 2006 Dec;61(6):1419-25.PMID: 17159685 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine.

    Pusateri AE, Ryan KL, Delgado AV, Martinez RS, Uscilowicz JM, Cortez DS, Martinowitz U.

    Thromb Haemost. 2005 Feb;93(2):275-83.PMID: 15711743 [PubMed - indexed for MEDLINE]Related articles

    12.

    The potential use of recombinant activated factor VII in trauma and surgery.

    Sapsford W.

    Scand J Surg. 2004;93(1):17-23. Review.PMID: 15116814 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Potential role of recombinant factor VIIa as a hemostatic agent.

    Hedner U, Erhardtsen E.

    Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9. Review.PMID: 16224390 [PubMed - indexed for MEDLINE]Related articles

    14.

    Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.

    Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM.

    J Thromb Haemost. 2007 Feb;5(2):244-9. Epub 2006 Nov 27.PMID: 17129221 [PubMed - indexed for MEDLINE]Related articles

    15.

    Safety profile of recombinant factor VIIa.

    Roberts HR, Monroe DM 3rd, Hoffman M.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):101-8. Review.PMID: 14872430 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

    Mohr AM, Holcomb JB, Dutton RP, Duranteau J.

    Crit Care. 2005;9 Suppl 5:S37-42. Epub 2005 Oct 7. Review.PMID: 16221318 [PubMed - indexed for MEDLINE]Related articles

    17.

    Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases.

    Mathew P, Winter SS, Frost JD, Hanrahan J, Schwartz M, Jones JE.

    J Pediatr Hematol Oncol. 2003 Jun;25(6):499-502.PMID: 12794532 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant factor VIIa improves coagulopathy caused by liver failure.

    Brown JB, Emerick KM, Brown DL, Whitington PF, Alonso EM.

    J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):268-72.PMID: 12960648 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.

    Keeney M, Allan DS, Lohmann RC, Yee IH.

    Lab Hematol. 2005;11(2):118-23.PMID: 16024335 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.

    Sapsford W, Watts S, Cooper G, Kirkman E.

    J Trauma. 2007 Apr;62(4):868-79.PMID: 17426541 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data